These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15825551)

  • 1. Electrogastrography in patients with Parkinson's disease.
    Naftali T; Gadoth N; Huberman M; Novis B
    Can J Neurol Sci; 2005 Feb; 32(1):82-6. PubMed ID: 15825551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrogastrographyc activity in Parkinson's disease patients with and without motor fluctuations.
    Albani G; El Assawy N; Cattaldo S; De Gennaro M; Gregorini F; Pradotto L; Mauro A
    Mov Disord; 2011 Aug; 26(9):1737-40. PubMed ID: 21618609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric emptying time and gastric motility in patients with Parkinson's disease.
    Hardoff R; Sula M; Tamir A; Soil A; Front A; Badarna S; Honigman S; Giladi N
    Mov Disord; 2001 Nov; 16(6):1041-7. PubMed ID: 11748735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.
    Doi H; Sakakibara R; Sato M; Masaka T; Kishi M; Tateno A; Tateno F; Tsuyusaki Y; Takahashi O
    J Neurol Sci; 2012 Aug; 319(1-2):86-8. PubMed ID: 22632782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired gastric myoelectrical activity in patients with Parkinson's disease and effect of levodopa treatment.
    Lu CL; Shan DE; Chen CY; Luo JC; Chang FY; Lee SD; Wu HC; Chen JD
    Dig Dis Sci; 2004 May; 49(5):744-9. PubMed ID: 15259493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
    Kumar A; Mann S; Sossi V; Ruth TJ; Stoessl AJ; Schulzer M; Lee CS
    Brain; 2003 Dec; 126(Pt 12):2648-55. PubMed ID: 12937076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrogastrography for diagnosis of early-stage Parkinson's disease.
    Araki N; Yamanaka Y; Poudel A; Fujinuma Y; Katagiri A; Kuwabara S; Asahina M
    Parkinsonism Relat Disord; 2021 May; 86():61-66. PubMed ID: 33865071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.
    Barichella M; Cereda E; Cassani E; Pinelli G; Iorio L; Ferri V; Privitera G; Pasqua M; Valentino A; Monajemi F; Caronni S; Lignola C; Pusani C; Bolliri C; Faierman SA; Lubisco A; Frazzitta G; Petroni ML; Pezzoli G
    Clin Nutr; 2017 Aug; 36(4):1054-1061. PubMed ID: 27406858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
    Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
    Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irregular gastrointestinal drug absorption in Parkinson's disease.
    Nyholm D; Lennernäs H
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):193-203. PubMed ID: 18248312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
    Fernandez HH; Odin P
    Curr Med Res Opin; 2011 May; 27(5):907-19. PubMed ID: 21351823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyneuropathy in levodopa-treated Parkinson's patients.
    Szadejko K; Dziewiatowski K; Szabat K; Robowski P; Schinwelski M; Sitek E; Sławek J
    J Neurol Sci; 2016 Dec; 371():36-41. PubMed ID: 27871444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience.
    Bohlega S; Abou Al-Shaar H; Alkhairallah T; Al-Ajlan F; Hasan N; Alkahtani K
    Eur Neurol; 2015; 74(5-6):227-36. PubMed ID: 26618531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain fluctuations in Parkinson's disease].
    Yakovleva LA; Zalyalova ZA; Altunbaev RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9):41-44. PubMed ID: 26525814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor fluctuations in Parkinson's disease.
    Denny AP; Behari M
    J Neurol Sci; 1999 May; 165(1):18-23. PubMed ID: 10426141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
    Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D
    Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.